课题基金 / 基金详情

Clinical ophthalmic molecular diagnostics and discovery

Clinical ophthalmic molecular diagnostics and discovery
临床眼科分子诊断和发现
批准号:
10266916
负责人:
Robert Hufnagel
金额:
$99.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Robert Hufnagel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Ophthalmic Genetics Laboratory. was designed to gather and manage biospecimens and molecular diagnostic data for use in facilitating ophthalmic disease research through the NEI clinical service. Individuals have been recruited into multiple studies within the NEI clinical program, including NCT02077894, NCT01432847, NCT00378742, and NCT02471287. Diagnostic testing is sent through commercial labs. Specific tests are performed in-house via CLIA-certified genetic testing, including X-linked retinoschisis, blue cone monochromacy, and site-directed testing for familial segregation and research finding confirmation. Clinical reports are returned to clinic, and clinical phenotyping and molecular diagnostic results are directly compared and discussed in regular clinical molecular rounds meetings. For biospecimen management, over DNA samples from over 2000 patients and more than 20 patient cell lines are maintained within the laboratory. Represented heritable ocular conditions include but are not limited to: Achromatopsia, Albinism, Aniridia, Coloboma, Microphthalmia, Anophthalmia, Axenfeld-Rieger Syndrome, Best Disease, Bietti's Crystalline Dystrophy, Choroideremia, Cone Rod Dystrophy, Congenital Stationary Night Blindness, Corneal Dystrophy, Juvenile X-linked Retinoschisis, Leber Hereditary Optic Neuropathy (LHON), mitochondrial DNA disorders, Optic Atrophy Type 1, Pattern Dystrophy, Retinitis Pigmentosa, Sorsby Fundus Dystrophy, Stickler Syndrome and Stargardt Disease, and Usher Syndrome. The laboratory has also developed a bioinformatics pipeline for processing next-generation sequencing data, including panel, exome, and genome datasets, for annotating different variation types such as single nucleotide variants, insertions-deletions, large deletions, and duplications, and structural variations including translocations. Variant prioritization tools are developed by the lab using large disease cohorts, internal variant frequencies, and development of pipeline annotations such as variation constraint, in silico predictors, and published epigenomic datasets. As such, the Ophthalmic Genomics Laboratory is a fully integrated, clinical functional genomic laboratory supporting NEI clinical care, research efforts, and extramural collaborations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical ophthalmic molecular diagnostics and discovery
  • 批准号:
    10706142
  • 项目类别:
  • 资助金额:
    $119.02万
  • 财政年份:
    --
  • 负责人:
    Robert Hufnagel
  • 依托单位:
Genomic and epigenomic mechanisms of pediatric ocular disorders
  • 批准号:
    10020041
  • 项目类别:
  • 资助金额:
    $137.7万
  • 财政年份:
    --
  • 负责人:
    Robert Hufnagel
  • 依托单位:
National Ophthalmic Disease Genotyping and Phenotyping Network - eyeGENE
  • 批准号:
    10930588
  • 项目类别:
  • 资助金额:
    $99.99万
  • 财政年份:
    --
  • 负责人:
    Robert Hufnagel
  • 依托单位:
Clinical ophthalmic molecular diagnostics and discovery
  • 批准号:
    10020040
  • 项目类别:
  • 资助金额:
    $99.15万
  • 财政年份:
    --
  • 负责人:
    Robert Hufnagel
  • 依托单位:
海外基金